Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease

Journal of Pediatric Hematology/Oncology

Volumn 37, Issue 2, 2015, Pages e135-e137

  Ipe, Tina S ^a   Wilkes, Jennifer J ^b   Hartung, Helge D ^b   Westhoff, Connie M ^c   Chou, Stella T ^b   Friedman, David F ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c NEW YORK BLOOD CENTER   (United States)

Author keywords

alloimmunization; delayed hemolytic transfusion reaction; red blood cell transfusion; RH genotype; sickle cell disease

Indexed keywords

BILIRUBIN; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ANTIBODY; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; RHESUS D ANTIBODY; ALLOANTIBODY; BLOOD GROUP RHESUS SYSTEM; RHO(D) ANTIBODY; RHO(D) ANTIGEN;

ABDOMINAL PAIN; ARTICLE; BLOOD GROUP O; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CASE REPORT; CHILD; DENSITOMETRY; DRUG MEGADOSE; ERYTHROCYTE; FATIGUE; GEL ELECTROPHORESIS; GENOTYPE; HEMOGLOBINURIA; HUMAN; LEG PAIN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; URINALYSIS; URINE COLOR; ADVERSE EFFECTS; ANEMIA, SICKLE CELL; BLOOD; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP RHESUS SYSTEM; COMPLICATION; ERYTHROCYTE TRANSFUSION; IMMUNOLOGY; PAIN; PROGNOSIS; TRANSFUSION REACTION;

ANEMIA, SICKLE CELL; BLOOD GROUP INCOMPATIBILITY; CHILD, PRESCHOOL; ERYTHROCYTE TRANSFUSION; HUMANS; ISOANTIBODIES; MALE; PAIN; PROGNOSIS; RH-HR BLOOD-GROUP SYSTEM; RHO(D) IMMUNE GLOBULIN; TRANSFUSION REACTION;

EID: 84924178967     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000241     Document Type: Article

References (13)

1. Smith-Whitley K, Thompson AA. Indications and complications of transfusions in sickle cell disease. Pediatr Blood Cancer. 2012;59:358-364.
2. Chou ST, Jackson T, Vege S, et al. High prevalence of red blood alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood. 2013;122: 1062-1071.
3. O'Suoji C, Liem RI, Mack AK, et al. Alloimmunization in sickle cell anemia in the era of extended red cell typing. Pediatr Blood Cancer. 2013;60:1487-1491.
4. Miller ST, Kim HY, Weiner DL, et al. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion. 2013;53:704-709.
5. Silvy M, Tournamille C, Babinet J, et al. Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti Rh linked to partial Rh phenotype. Haematologica. 2014;99:e115-117.
6. Gorst DW, Rawlinson VI, Merry AH, et al. Positive direct antiglobulin test in normal individuals. Vox Sang. 1980;38: 99-105.
7. Zantek ND, Koepsell SA, Tharp DR Jr, et al. The direct antiglobulin test: a critical step in the evaluation of hemolysis. Am J Hematol. 2012;87:707-709.
8. Win N. Hyperhemolysis syndrome in sickle cell disease. Expert Rev Hematol. 2009;2:111-115.
9. Lasalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center. Transfusion. 2011;51:1732-1739.
10. Wagner FF, Ladewig B, Angert KS, et al. The DAU allele cluster of the RHD gene. Blood. 2002;100:306-311.
11. Talano JA, Hillery CA, Gottschall JL, et al. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics. 2003;111(pt 1):e661-e665.
12. Roubinet F, Apoil PA, Blancher A. Frequency of partial D phenotypes in the south western region of France. Transfus Clin Biol. 1996;3:247-255.
13. Reid ME, Hipsky CH, Hue-Roye K, et al. Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease. Blood Cells Mol Dis. 2013;52:195-202.